Türk Toplumunda İlk Gözlemlenen Hemoglobin Jabalpur [Beta 3 (NA3) Leu>Pro]

Journal Title: Turkish Journal of Hematology - Year 2014, Vol 31, Issue 3

Abstract

Authors and Affiliations

Ayfer Çolak, Burak Toprak, Kanay Yararbaş, Fatma Akyol, Cengiz Ceylan

Keywords

Related Articles

Phenotype Report on Patients with Congenital Factor V Deficiency in Southern Iran: Recent Ten Years’ Experience

This study aimed to investigate clinical symptoms in patients with congenital factor V (FV) deficiency and the relationship between phenotype and factor activity level. Thirteen patients with congenital FV deficiency wer...

Clinical Trials in Turkey

Turkey is an emerging economy in almost all sectors, and especially in pharmaceuticals. Turkey has had clinical trial legislation for a long time. There are also clinical trial regulations and guidelines. Turkey has take...

Download PDF file
  • EP ID EP142679
  • DOI 10.4274/tjh.2014.0027
  • Views 74
  • Downloads 0

How To Cite

Ayfer Çolak, Burak Toprak, Kanay Yararbaş, Fatma Akyol, Cengiz Ceylan (2014). Türk Toplumunda İlk Gözlemlenen Hemoglobin Jabalpur [Beta 3 (NA3) Leu>Pro]. Turkish Journal of Hematology, 31(3), 319-320. https://europub.co.uk/articles/-A-142679